5 Amino 1MQ – 50mg
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that enhances metabolic function and cellular energy regulation. Research demonstrates 5-Amino-1MQ significantly reduces body weight and fat mass while preserving lean muscle tissue. Studies show treatment produces approximately 35% reduction in white adipose tissue mass and 5.1% body weight loss without affecting food intake. The compound increases intracellular NAD+ levels, enhancing mitochondrial function and metabolic efficiency. In aged mice, 5-Amino-1MQ improves grip strength by approximately 40%, enhances muscle regeneration capacity twofold, and increases contractile force by 70% following injury, demonstrating powerful effects on muscle preservation and recovery.
5 Amino 1MQ – 75mg
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that enhances metabolic function and cellular energy regulation. Research demonstrates 5-Amino-1MQ significantly reduces body weight and fat mass while preserving lean muscle tissue. Studies show treatment produces approximately 35% reduction in white adipose tissue mass and 5.1% body weight loss without affecting food intake. The compound increases intracellular NAD+ levels, enhancing mitochondrial function and metabolic efficiency. In aged mice, 5-Amino-1MQ improves grip strength by approximately 40%, enhances muscle regeneration capacity twofold, and increases contractile force by 70% following injury, demonstrating powerful effects on muscle preservation and recovery.
Adamax 5mg
Adamax is a synthetic nootropic peptide of the melanocortin/ACTH family, structurally derived from the heptapeptide Semax (ACTH 4-7 + Pro-Gly-Pro) with an adamantane modification that increases enzymatic stability, lipophilicity, and blood-brain barrier penetration. Research on the Semax scaffold demonstrates upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the hippocampus, enhanced learning and memory retention, and marked neuroprotection in cerebral ischemia models. A single dose of Semax raised hippocampal BDNF protein 1.4-fold and TrkB phosphorylation 1.6-fold, supporting neuronal survival, synaptic plasticity, and cognitive resilience under stress.
AOD 9604 5mg
AOD 9604 is a synthetic 16-amino acid peptide fragment derived from the C-terminal region (amino acids 176-191) of human growth hormone. Research demonstrates AOD 9604 significantly enhances lipolytic activity and reduces body weight gain by upregulating beta-3 adrenergic receptors in adipose tissue. In clinical trials involving 925 participants, AOD 9604 increased fat metabolism without affecting insulin sensitivity, glucose tolerance, or IGF-1 levels. Studies show AOD 9604 reduces body weight by 1.8-2.6 kg more than placebo over 12 weeks while demonstrating excellent safety and tolerability profiles. The peptide promotes cartilage regeneration in osteoarthritis models and enhances joint repair when combined with hyaluronic acid, with no serious adverse events related to treatment across multiple controlled trials.
ARA-290 10mg
ARA-290 is an 11-amino acid synthetic peptide derived from the tissue-protective domain of erythropoietin (EPO) that selectively activates the innate repair receptor without stimulating red blood cell production. Research demonstrates ARA-290 significantly reduces neuropathic pain, promotes nerve regeneration, and enhances tissue repair through potent anti-inflammatory mechanisms. Clinical studies show improvements in diabetic neuropathy symptoms, corneal nerve fiber density increases, and enhanced metabolic control including reduced HbA1c and improved lipid profiles. The peptide protects organs from ischemic injury, accelerates wound healing, enhances survival of transplanted islet cells, and preserves cardiac function during aging by suppressing inflammatory cytokines and activating cellular repair pathways.
BPC-157 10mg
BPC-157 is a 15-amino acid pentadecapeptide derived from a protective gastric protein found in human gastric juice. Research demonstrates BPC-157 accelerates healing across multiple tissue types including tendons, ligaments, muscles, bones, and gastrointestinal tract. Animal studies show the peptide promotes angiogenesis through VEGFR2 activation and enhances tissue regeneration via the FAK-paxillin and nitric oxide signaling pathways. BPC-157 has demonstrated efficacy in repairing transected tendons and ligaments, healing muscle injuries, accelerating bone fracture recovery, and treating gastrointestinal ulcers and inflammatory bowel conditions. The peptide exhibits cytoprotective and anti-inflammatory properties while maintaining stability in gastric juice for over 24 hours.
BPC-157 10mg TB-500 10mg Blend
BPC-157 and TB-500 represent a synergistic peptide combination designed for comprehensive tissue repair and regeneration. BPC-157, a 15-amino acid gastric peptide, promotes angiogenesis, collagen synthesis, and local tissue healing, while TB-500, derived from thymosin beta-4, enhances cellular migration, reduces inflammation, and supports systemic recovery. Research demonstrates this combination accelerates wound healing, improves tendon and ligament repair, enhances muscle regeneration, and reduces scar formation. The peptides work through complementary mechanisms—BPC-157 stimulating growth factors and vascular formation at injury sites, while TB-500 facilitates cell migration through actin regulation. Studies show synergistic effects exceeding individual peptide benefits, with applications in musculoskeletal injuries, post-surgical recovery, chronic inflammation, and connective tissue repair.
Cagrilintide 10mg
Cagrilintide is a long-acting, lipidated amylin analog engineered for once-weekly administration in the treatment of obesity and type 2 diabetes. This synthetic peptide activates both amylin and calcitonin receptors, promoting satiety through actions on brainstem appetite centers while delaying gastric emptying. Clinical trials demonstrate dose-dependent weight reductions of 6-11% with monotherapy, and up to 20-23% when combined with semaglutide. Research shows cagrilintide significantly improves glycemic control, reducing HbA1c by 2.2% in combination therapy, while enhancing insulin sensitivity and glucose metabolism. The peptide demonstrates cardiometabolic benefits including reductions in blood pressure, improvements in lipid profiles, and decreased inflammatory markers.
Cardiogen 20mg
Cardiogen is a synthetic tetrapeptide bioregulator composed of four amino acids (Ala-Glu-Asp-Arg) that demonstrates significant cardiovascular protective properties through gene expression modulation. Research shows Cardiogen stimulates cardiomyocyte proliferation while regulating fibroblast activity to reduce excessive scar tissue formation in cardiac tissue. Studies indicate the peptide enhances synthesis of cytoskeletal proteins including actin, vimentin, and tubulin, while increasing nuclear matrix proteins lamin A and C by up to 2.5-fold. Cardiogen reduces p53 protein expression, thereby inhibiting apoptosis in myocardial cells and promoting cardiac tissue preservation. The peptide demonstrates tissue-specific action on cardiac cells, with research showing maintained efficacy in both young and aged tissue cultures.
Cartalax 20mg
Cartalax is a synthetic tripeptide bioregulator (Ala-Glu-Asp; AED sequence) developed through research on cartilage tissue extracts. Studies demonstrate Cartalax modulates cellular aging pathways by reducing senescence markers p16, p21, and p53 while increasing SIRT-6 expression associated with longevity. Research shows the peptide enhances cell proliferation through increased Ki-67 expression, reduces apoptosis via caspase-3 suppression, and inhibits matrix metalloproteinase-9 (MMP-9) activity linked to tissue degradation. In fibroblast studies, Cartalax stimulates collagen type I and sirtuin production while modulating inflammatory markers. The peptide regulates chondrogenic differentiation pathways including WNT, ERK-p38, and Smad 1/5/8 signaling, promoting expression of cartilage-specific proteins COL2, SOX9, and ACAN in mesenchymal stem cells.
Chonluten 20mg
Chonluten is a synthetic tripeptide bioregulator composed of three amino acids (Glutamic acid-Aspartic acid-Glycine) originally derived from bronchial epithelial tissue. Research demonstrates Chonluten functions as an anti-inflammatory agent that modulates immune cell activity and cytokine production. Studies show the peptide inhibits tumor necrosis factor (TNF) production in monocytes and reduces pro-inflammatory cytokines IL-6 and IL-17. Chonluten activates STAT1 signaling pathways and induces TNF tolerance in macrophages, promoting resolution of inflammatory responses. The peptide demonstrates tissue-specific effects on respiratory epithelium through gene expression regulation. Research indicates Chonluten reduces immune cell adhesion to vascular endothelium and modulates proliferative patterns in immune cells.
CJC 1295 No DAC – Ipamorelin Blend 5mg/5mg
CJC-1295 (no DAC) and Ipamorelin represent a synergistic peptide blend combining a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone-releasing peptide (GHRP). This combination stimulates endogenous growth hormone release through complementary mechanisms, producing enhanced and sustained GH pulses. CJC-1295 (no DAC) amplifies GH secretion amplitude while Ipamorelin increases pulse frequency, together creating a natural pulsatile pattern. Research demonstrates this combination significantly elevates growth hormone and IGF-1 levels, promoting lean muscle development, enhanced fat oxidation, improved tissue repair, and accelerated recovery. The blend preserves selectivity for GH release without affecting cortisol or prolactin, offering benefits for body composition, metabolic function, and physical performance enhancement.